The Crossroads of Special Operations

Tuesday, May 18, 2021

FDA approves Army-developed battlefield TBI blood test | Army Times

Must Read

After decades of researchers trying to find a way to quicky detect and diagnose TBI, the FDA has approved a rapid blood test. “A rapid test for TBI is a critical addition to our downrange capability to care for the brain health of our most important weapon system, the warfighter, and help maintain a high state of readiness across the Force,” stated Army Brig. Gen. Michael J. Talley. Over the last 20 years more than 400,000 troops sustained a TBI. The test is known as the “Abbott i-STAT Alinity TBI plasma assay” and detects two brain-specific protein markers that appear after a TBI incident.

Source: https://www.armytimes.com/news/your-army/2021/01/28/fda-approves-army-developed-battlefield-tbi-blood-test/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+air-force-times%2Fnews%2Fyour-air-force+%28Air+Force+Times+-+Arc+RSS+-+Your+Air+Force%29

- Advertisement -spot_img

- Advertisement -

Latest News

Cold front: Special Operations Forces bracing for Arctic missions | National Defense

For more than 20 years US Special Operations Forces have been deployed to some of the world's deadliest and...

- Advertisement -

More Articles Like This

- Advertisement -spot_img